All Articles

Unify Energy Solutions just secured a major war chest for acquisitions. Here’s the why behind the buy in the booming smart building and energy efficiency market.

A new study shows Therabody's recovery devices can erase the halftime performance drop. Is this the future of how athletes prepare for the second half?

A new radar system born from military special ops promises to track bullets, not just sound. Can it overcome the controversies plaguing existing gunshot detectors?

While auto theft in Quebec hits a decade low, the soaring cost of repairing high-tech vehicles is creating a new financial headache for drivers and insurers.

As demand for home care soars, BrightStar Care's rapid franchise expansion is underpinned by a strict system of quality, new leadership, and AI innovation.

OEMs are no longer just buying components; they're buying engineering certainty. A look at how suppliers are becoming deep-seated partners to manage risk.

Shionogi launches XOCOVA, the first oral pill to prevent COVID after exposure. With a 67% efficacy rate and a $1,400 price tag, who will it protect?

As CFO Vik Kini prepares for a key investor chat, Ingersoll Rand's strategy offers a crucial look into the future of manufacturing, M&A, and market resilience.

A new Franco-European alliance aims to build the future of AI networking, challenging Silicon Valley's dominance and betting on an open standard to power the next generation.

OneMedNet's massive data deal promises to revolutionize medical AI. I investigate the high-stakes world of 'regulatory-grade' data and patient privacy.

A sharp 26% drop in Medical Outpatient Building M&A reveals a market grappling with high interest rates, but strategic acquirers still find opportunity.

Unveiling a new identity at Gamescom, Payop's strategic shift to seamless payments aims to eliminate friction for players and unlock global markets for developers.

A federal court ordered Papaya Gaming to pay Firy Inc. $719M for cheating players with bots. This record verdict validates Firy's business model and sets a new, costly precedent for fair play.

A new study argues state-imposed price caps on drugs fail to lower patient costs, instead threatening the supply chain for our most vulnerable citizens.

In a rising market, 83% of elite US Investing Championship traders failed to profit. How did a few achieve quadruple-digit returns while most lagged behind?

FITCRUNCH's new Puff N' Crunchy bar is more than a snack; it's a strategic move in a high-stakes market, leveraging texture and taste to fuel a comeback.

Apple's 'Upgrade' program makes getting the latest tech easier, but is this subscription future a smart financial move or a costly commitment? We dive deep.

Gaxos.ai's strategic pivot away from gaming has fueled a massive revenue surge. But beyond the headline numbers, can it achieve profitability and prove its AI identity?

Royal Canin's new Amazon partnership is more than a convenience play; it's a calculated move by Mars to dominate the booming pet health e-commerce space.